Pfizer's antiviral Covid-19 pill reduced the risk of hospitalization or death by 89 percent in high-risk patients who’d been experiencing symptoms for three days or less
in high-risk patients who’d been experiencing symptoms for three days or less, according to final results from a trial of 2,246 adults the company released Tuesday.
A second analysis of unvaccinated people at standard risk of developing Covid-19 symptoms found the drug reduced hospitalizations by 70 percent but didn't meet the target goal, the company said. The results were shared with the FDA as part of the company's application but have not been reviewed by outside scientists.
The availability of an oral medication that can treat Covid symptoms and keep most patients out of the hospital could be a game changer for the course of the pandemic. Pills are easier to manufacture and distribute than therapies like monoclonal antibodies, which are administered in health care settings.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer: Final data on pills to treat Covid-19 holds strong against hospitalization and deathPfizer's updated results for its experimental treatment for Covid-19 showed it cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms, the company announced in a news release Tuesday.
Weiterlesen »
Pfizer Says Its Covid-19 Pill Likely Works Against OmicronPfizer’s Covid-19 pill, which is up for FDA authorization, worked against Omicron in lab tests, the company said. A final analysis of a key study also confirmed the drug was 89% effective in high-risk adults.
Weiterlesen »
Pfizer says COVID-19 pill near 90% effective in final analysisPfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.
Weiterlesen »
Pfizer says its COVID-19 treatment pill works against the Omicron variantThe company says the full results of its study of the pill confirm promising early findings of the drug's protection against hospitalization and death.
Weiterlesen »
Pfizer's Covid pill 89 percent effective at keeping people out of hospital or dying, company saysAdditional data on Pfizer's Covid oral antiviral pill suggests the pill is highly effective. The FDA has not yet scheduled a meeting of its advisory committee to reivew the pill.
Weiterlesen »
Britain Confirms World's First Known COVID-19 Omicron Variant DeathThe death comes amid speculation, absent sufficient evidence, that omicron might cause less severe disease than its predecessors.
Weiterlesen »